Aurora Cannabis announces the filing of the preliminary shelf prospectus

NYSE | TSX: ACB

EDMONTON, AB, March 10, 2021 / CNW / – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company that defines the future of cannabinoids worldwide, announced today that it has a new preliminary Briefly has filed prospectus (the “Base Prospectus”) with securities regulators in each of the provinces of Canada, except Quebecand a corresponding shelf registration statement on Form F-10 (the “Registration Statement”) with the US Securities and Exchange Commission (“SEC”).

The final base prospectus qualifies common stocks, preferred stocks, warrants, subscription receipts and bonds up to US$ 1 billion during the period of 25 months in which the base shelf prospectus is still valid. Management believes that filing this new basic shelf prospectus is in the best interests of shareholders and provides maximum flexibility in pursuing strategic initiatives, including acquisitions or partnerships in accordance with the company’s pre-determined global growth strategy.

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquarters in Edmonton, AlbertaAurora is a pioneer in global cannabis helping people improve their lives. The company’s portfolio of brands includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Aurora’s brands deliver innovative, high quality cannabis products to their customers and continue to lead the industry in medical, performance, wellness and leisure wherever they are introduced. For more information, please visit our website at www.auroramj.com.

Aurora common stock trades on the TSX and NYSE under the symbol “ACB” and is part of the S & P / TSX Composite Index.

Forward-Looking Statements

This press release contains statements that contain certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are often identified by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential” “,” suggested “and other similar words or statements suggest that certain events or conditions” may “or” will “occur. Forward-looking statements in this press release include statements regarding the filing of a prospectus addendum below and the pursuit of strategic initiatives. These forward-looking statements are only predictions. Various assumptions have been made in order to reach conclusions or to predict the forward-looking statements contained in this press release. Forward-looking statements are based on the opinions, estimates and assumptions of management in the light of management’s experience and the perception of historical trends, current conditions and expected developments at the time the statements are made, such as current and future market conditions, the ability to Cost in line with current expectations, the ability to generate high margin income in the Canadian consumer market, current and future regulatory environments, and future permits and permits. Forward-looking statements are subject to a number of risks, uncertainties and other factors that management believes are relevant and appropriate in the given circumstances and that could cause actual events, results, levels of activity, performance, prospects, opportunities or successes to differ materially from them Projected in the forward-looking statements, including the risks associated with entering the U.S. market, the ability to realize the anticipated benefits related to the Reliva acquisition, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in law and the associated risks include regulations, product demand, changes in the price of required goods, competition, effects and reactions to the COVID-19 pandemic and other risks, uncertainties and factors that are covered under the heading “Risk Factors” in the annual informati Company’s onsheet is dated September 24, 2020 (the “AIF”) and filed with the Canadian Securities and Exchange Commission, which are available on the Company’s Issuer Profile on SEDAR at www.sedar.com and filed and available on the SEC’s website at www.edgar.gov. The company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and that other factors could also affect results. Readers are cautioned to carefully consider the risks, uncertainties and assumptions in evaluating any forward-looking statements and are cautioned not to place undue reliance on such information. The company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements as a result of new information, future events or for other reasons, unless this is expressly required by the applicable securities law.

SOURCE Aurora Cannabis Inc.

For more information: For the media: Michelle Lefler, VP, Communications & PR, [email protected];; For investors: ICR, Inc., Investor Relations, [email protected]

similar links

https://auroramj.com/

Comments are closed.